Billings Clinic
Especially For:

Clinical Trials

Title   GI Advanced Gallbladder Carcinoma or Cholangiocarcinoma
Description   S0941 Phase II Study of Sorafenib and Erlotinib in Patients with Advanced Gallbladder and Carcinoma or Cholangiocarcinoma
IRB Number   S0941
Category   Gastrointestinal
Inclusion/Notes   Must have Measurable Disease
No prior treatment for metastatic disease may have a had adjuvant.
Unresectable

Please contact Tricia Montgomery for additional inclusion/exclusion criteria.
Status   Active
Start Date   05/14/2010
Principal Investigator (PI)   Jorge Nieva, MD
Physician Profile   Medical Oncologist
Contact Name   Trica Montgomery RN
Contact Email   tmontgomery@billingsclinic.org
Phone   (406) 435-7483
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.